Forming a national multicentre collaboration to conduct clinical trials: Increasing high-quality research in the drug and alcohol field

Drug and Alcohol Review

Volumn 29, Issue 5, 2010, Pages 469-474

  Sanson Fisher, Rob ^a   Brand, Matthew ^b   Shakeshaft, Anthony ^c   Haber, Paul ^c,d,e,f   Day, Carolyn ^d,e   Conigrave, Katherine ^c,d,e   Mattick, Richard ^c   Lintzeris, Nicholas ^c,d,e,f   Teesson, Maree ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e University of Sydney   (Australia)

^f SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

Clinical trial; Collaborative research; Drug and alcohol; Intervention; Multicentre trial

Indexed keywords

ADDICTION; ALCOHOLISM; ARTICLE; AUSTRALIA; CLINICAL TRIAL (TOPIC); COOPERATION; ECONOMICS; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HUMAN; METHODOLOGY; MULTICENTER STUDY (TOPIC); STANDARD;

ALCOHOLISM; AUSTRALIA; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; MULTICENTER STUDIES AS TOPIC; RESEARCH SUPPORT AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 77957897472     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00166.x     Document Type: Article

References (40)

1. WHO. The world health report 2002. Geneva: World Health Organization, 2002.
2. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD. The burden of disease and injury in Australia 2003. Canberra: Australian Institute of Health andWelfare, 2007.
3. Sanson-Fisher RW, Campbell E, Htun AT, Bailey LJ, Millar CJ. We are what we do: research outputs of public health. Am J Prev Med 2008;35:380-5.
4. NHMRC. How to review the evidence: systematic identification and review of the scientific literature. Canberra: Biotext, 1999.
5. NHMRC. How to use the evidence: assessment application of scientific evidence. Canberra: National Health and Medical Research Council, 2000.
6. Vigna-Taglianti F, Mathis F, Foxcroft D, Amato L, Faggiano F. The use of non-randomized studies in the Cochrane reviews on drug and alcohol. Melbourne, Australia: XIII Cochrane Colloquium 2005:149.
7. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions 4.2.6. 2006: 1-257. Available at: http://www.cochrane.org/resources/handbook/Handbook4.2.6Sep2006.pdf (accessed November 2007).
8. Cochrane Drugs and Alcohol Group. Resources for review authors. Available at: http://www.cdag.cochrane.org/en/authors.html (accessed November 2007).
9. Moyer A, Finney JW, Swearingen CE. Methodological characteristics and quality of alcohol treatment outcome studies, 1970-98: an expanded evaluation. Addiction 2000;97:253-63.
10. Shand F, Gates J, Fawcett J, Mattick R. The treatment of alcohol problems: a review of the evidence. Canberra: Department of Health and Aging, 2003:141.
11. Ashery R, McAuliffe W. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992;18:305-29.
12. Thomson CL, Morley KC, Teesson M, Sannibale C, Haber PS. Issues with recruitment to randomised controlled clinical trials in the drug and alcohol field: a literature review and Australian case study. Drug Alcohol Rev 2008;27:115-22.
13. Epstein EE, McCrady BS, Miller KJ, Steinberg M. Attrition from conjoint alcoholism treatment: do dropouts differ from completers? J Subst Abuse 1994;6:249-65.
14. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 1987;8:6S-30S.
15. Jackson M, Berman N, Huber M, et al. Research staff turnover and participation adherence in the Women's Health Initiative. Control Clin Trials 2003;24:422-35.
16. Knudsen HK, Ducharme LJ, Roman PM. Research participation and turnover intention: an exploratory analysis of substance abuse counselors. J Subst Abuse Treat 2007;33: 211-17.
17. Sibthorpe BM, Bailie RS, Brady MA, Ball SA, Sumner-Dodd P, Hall WD. The demise of a planned randomised controlled trial in an urban Aboriginal medical service. Med J Aust 2002;177:222-3.
18. Chaturvedi HK, Mahanta J. Sociocultural diversity and substance use pattern in Arunachal Pradesh, India. Drug Alcohol Depend 2004;74:97-104.
19. Hilton ME. Regional diversity in United States drinking practices. Br J Addict 1998;83:519-32.
20. Australian Bureau of Criminal Intelligence. Australian illicit drug report 1998-99. Canberra: Australian Bureau of Criminal Intelligence, 2000.
21. McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: dissemination research in an addiction treatment system. J Subst Abuse Treat 2004;26:305-12.
22. Mosher C, Rotolo T, Phillips D, Krupski A, Stark KD. Minority adolescents and substance use risk/protective factors: a focus on inhalant use. Adolescence 2004;39:489-502.
23. Moncher MS, Schinkie SP, Holden GW, Aragon S. Tobacco by American Indian youth. JAMA 1989; 262:1469-70.
24. Kelder SH, Murray NG, Orpinas P, Prokhorov A. Depression and substance use in minority middle-school students. Am J Public Health 2001;91:761-6.
25. Research, Development and Statistics Directorate. The substance misuse treatment needs of minority prisoner groups: women, young offenders and ethnic minorities. London: Research, Development and Statistics Directorate, 2003.
26. Brown TL, Miller JD, Clayton RR. The generalizability of substance use predictors across racial groups. J Early Adolesc 2004;24:274-302.
27. Meisenhelder JB, Kalinoski J, Saunders JM. Perceived barriers to getting published: results of the JANAC survey. J Assoc Nurses AIDS Care 1995;6:57-62.
28. Conn VS, Porter RT, McDaniel RW, Rantz MJ, Maas ML. Building research productivity in an academic setting. Nurs Outlook 2005;53:224-31.
29. National Health Service. Putting NHS research on the map: an analysis of scientific publications in England 1990-97. London: National Health Service, 2001.
30. Mattick RP, Digiusto E, Doran C, et al. National evaluation of pharmacotherapies for opioid dependence (NEPOD): report of results and recommendations. Canberra: National Drug and Alcohol Research Centre, 2004.
31. World Health Organisation. Handbook for good clinical research practice (GCP): guidance for implementation. Geneva: World Health Organisation, 2002.
32. Australian Government Department of Health and Ageing Therapeutic Goods Administration. The Australian clinical trial handbook: a simple, practical guide to the conduct of clinical trials to International standards of good clinical practice (GCP) in the Australian context. Canberra: Commonwealth of Australia, 2006.
33. Lopez-Carrero C, Arriaza E, Bolanos E, et al. Internet in clinical research based on a pilot experience. Contemp Clin Trials 2005;26:234-43.
34. Torgerson JS, Arlinger K, Kappi M, Sjostrom L. Principles for enhanced recruitment of subjects in a large clinical trial: the XENDOS study experience. Control Clin Trials 2001;22:515-25.
35. Breitfeld PP, Ullrich F, Anderson J, Crist WM. Web-based decision support for clinical trial eligibility determination in an international clinical trials network. Control Clin Trials 2003;24:702-10.
36. Estellat C, Tubach F, Costa Y, Hoffmann I, Mantz J, Ravaud P. Data capture by digital pen in clinical trials: a qualitative and quantitative study. Contemp Clin Trials 2008;29:314-23.
37. Naydeck BL, Sutton-Tyrell K, Burek K, Sopko GS. Organizational structure and communication strategies of the bypass angioplasty revascularization investigator: a multicenter clinical trial. Control Clin Trials 1996;17:226-334.
38. Curley RM, Evans RL, Kaylor J, Pogash RM, Chinchilli VM. Development and deployment of internet-based data management system for use by the Asthma Clinical Research Network. Control Clin Trials 2001;22:S135-55.
39. Abdellatif M, Reda DJ. A Paradox®-based data collection and management system for multi-centre randomized clinical trials. Comput Methods Programs Biomed 2004;73: 145-64.
40. Bleicher P. Clinical trial technology: at the inflection point. Biosilico 2003;1:163-8.